Matter of Ladapo (Altagracia D.)

2025 NY Slip Op 50354(U)
CourtNew York Supreme Court, Queens County
DecidedMarch 21, 2025
DocketIndex No. 500485/2025
StatusUnpublished
Cited by1 cases

This text of 2025 NY Slip Op 50354(U) (Matter of Ladapo (Altagracia D.)) is published on Counsel Stack Legal Research, covering New York Supreme Court, Queens County primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Matter of Ladapo (Altagracia D.), 2025 NY Slip Op 50354(U) (N.Y. Super. Ct. 2025).

Opinion

Matter of Ladapo (Altagracia D.) (2025 NY Slip Op 50354(U)) [*1]
Matter of Ladapo (Altagracia D.)
2025 NY Slip Op 50354(U)
Decided on March 21, 2025
Supreme Court, Queens County
Dunn, J.
Published by New York State Law Reporting Bureau pursuant to Judiciary Law § 431.
This opinion is uncorrected and will not be published in the printed Official Reports.


Decided on March 21, 2025
Supreme Court, Queens County


In the Matter of the Application of Dr. Ademola Ladapo,
Director of Adult Inpatient Psychiatry, Department of Psychiatry,
City Hospital Center at Elmhurst, Petitioner,

For an order authorizing the medication of and performance of routine lab work
and EKG upon Altagracia D., a patient at said hospital, Respondent.




Index No. 500485/2025

For the petitioner:
McAloon & Friedman, P.C.
Attorneys for the Petitioner
One State Street Plaza
New York, New York 10004
By: Fernando Mercado, Esq.

For patient:
Mental Hygiene Legal Services
3333 New Hyde Park Road, Suite 306
New Hyde Park, New York 11042
By: Brendan Barnes, Esq. Scott Dunn, J.

I. INTRODUCTION

Altagracia D. ("Altagracia D." or "Respondent") is a patient at Elmhurst Hospital ("the "Hospital" or "Petitioner"). The Hospital filed an Order to Show Cause seeking to involuntarily medicate Altagracia D and to authorize the performance of routine lab work and an EKG. [*2]Respondent opposes the application. As such, a hearing was held before this Court on March 13, 2025, regarding the Order to Show Cause. Altagracia D. did not attend that hearing, and, neither did any of the Hospital staff involved in her treatment. Following, the hearing, the Court rendered an oral decision denying the Hospital's application without prejudice to renew. The Court now renders its written decision to more fully set forth its reasoning.

II. FACTS

By Order to Show Cause dated March 10, 2025, the Hospital commenced this action, pursuant to the Mental Hygiene Law, seeking, in the main, an order to compel the administration of medication on Respondent. The Order to Show Cause was supported by the Petition of Dr. Ademola Ladapo, the Director of Adult Inpatient Psychiatry, Department of Psychiatry, at the Hospital, and Dr. Emmanuelle Duterte, an attending physician, Department of Psychiatry at the Hospital, who oversaw Respondent's treatment and care. Specifically, the Hospital sought authorization to medicate the Respondent with Haldol, with the option to convert to Haldol Decanoate, Prolixin, Risperidone and Clozapine. The Hospital also sought authorization to administer Ativan. Finally, the Hospital sought authorization to administer various laboratory tests as well as an EKG (see the Order to Show Cause).

On March 13, 2025, a hearing was held on the Hospital's application. The Hospital presented one witness, Dr. Kamil Dar. Counsel for Respondent stipulated to Dr. Dar's expertise in the field of psychiatry as well as to the admission of the Hospital records for the current admission of the Respondent, subject to redaction. Tr.[FN1] at p. 2.

Dr. Dar testified that the Respondent was admitted to the Hospital on February 28, 2025. Tr. at 3. He testified that she presented with a disorganized thought process, was very irritable, internally preoccupied and agitated. Tr. at 3. Based on the above, Altagracia D. was diagnosed with Schizophrenia. Tr. at 3. Dr. Dar further testified that Respondent lacked insight into her mental illness and lacked the capacity to make a reasoned decision regarding her medication. Tr. at 3. Dr. Dar based his conclusion on the Respondent's disorganized thought processes and her internal preoccupation which led her to refuse to accept medication because "someone has been telling her not to take meds" Tr. at 3. Dr. Dar noted, however, that the Respondent had not shown any aggressive behavior while at the Hospital. Tr. at 3.

Dr. Dar further testified as to the medications that the Hospital sought to administer. Tr. at 4. Dr. Dar testified that the Hospital had attempted to discuss the proposed medical treatment with the Respondent, but that the Respondent had refused to engage in discussions relating to her treatment and was in any event, not able to comprehend the suggested treatment. Tr. at 4. Finally, Dr. Dar testified that the proposed medical treatment was optimal for the Respondent, that the benefits of treatment would outweigh any risks, that any side effects could be monitored, and that he did not have any health concerns about her taking the medication. Tr. at 5.

On cross-examination, Dr. Dar acknowledged that the Respondent's primary care provider was Ms. Osbourne, a nurse practitioner. Tr. at 6. Dr. Dar further testified that Dr. Duterte was the supervising psychiatrist on the Respondent's case, but that Dr. Duterte could not testify at the hearing as she was "not here today and for the remainder of the week " Tr. at 7. As such, Dr. Dar testified that he was in court covering for her and that he had taken over the matter on the day of the hearing. Tr. at 7. In this regard, Dr. Dar acknowledged that he had never spoken with the Respondent, had never met her, and had reviewed her records for the first time the day before the hearing. Tr. at 7. Indeed, Dr. Dar ultimately testified that while he did have a discussion with Dr. Duterte, that he did not have an independent assessment of the Respondent, but that his assessment was based solely on the notes that he read. Tr. at 11.

In terms of the treatment itself, Dr. Dar acknowledged that he did not know if the Respondent had taken Haldol, Prolixin, or Risperdal before admittance to the Hospital. Tr. at 8. Dr. Dar did testify, however, that he believed that the Respondent had been taking Clozapine "but stopped it" because of lab abnormalities. Tr. at 8. Specifically, Dr. Dar testified that based on the notes that he reviewed, the outpatient psychiatrist withheld the plan to restart Clozapine because the labs showed that the Respondent had a low Neutrophil count. Tr. at 8. Dr. Dar testified that Neutrophil is a type of white blood cell and white blood cells are necessary for providing for defense against any form of infection. As such, Dr. Dar stated that a low Neutrophil count increases the risk of infection. Tr. at 9. In this regard, Dr. Dar testified that one of the side effects of Clozapine could be to lower the Neutrophil count and that could possibly be dangerous. Tr. at 9. He also testified that Haldol, Prolixin, and Risperdal could have similar side effects. Tr. at 9.



III. DISCUSSION

A. Legal Standard

In this State, where, as here, an entity wishes to rely on its parens patriae power to force administration of a medical procedure on an unwilling patient, that entity must satisfy the test set forth in Rivers v. Katz (67 NY2d 485 [1986]). Pursuant to Rivers v. Katz, as a threshold matter, the State bears the burden of demonstrating by clear and convincing evidence the patient's incapacity to make a treatment decision (67 NY2d at 497).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Matter of Ladapo (Altagracia D.)
2025 NY Slip Op 50354(U) (New York Supreme Court, Queens County, 2025)

Cite This Page — Counsel Stack

Bluebook (online)
2025 NY Slip Op 50354(U), Counsel Stack Legal Research, https://law.counselstack.com/opinion/matter-of-ladapo-altagracia-d-nysupctqueens-2025.